Pneumonia virus of mice: severe respiratory infection in a natural host

Immunology Letters

Volumn 118, Issue 1, 2008, Pages 6-12

  Rosenberg, Helene F ^a   Domachowske, Joseph B ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Chemokine; Epithelial; Granulocyte; Inflammation; Lymphocyte

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; IMMUNOMODULATING AGENT; INTERFERON RECEPTOR; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA ANTIBODY; MET RANTES; MONTELUKAST; RIBAVIRIN; TOLL LIKE RECEPTOR 4;

AGING; ALLERGY; ANTIVIRAL THERAPY; CELLULAR IMMUNITY; DISEASE SEVERITY; DRUG EFFICACY; EXPERIMENTAL INFECTION; GENETIC ORGANIZATION; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; MORBIDITY; MORTALITY; MURINE PNEUMONIA VIRUS; NATURAL HOST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; REVIEW; SURVIVAL TIME; T LYMPHOCYTE; TH2 CELL; TREATMENT RESPONSE; VACCINATION; VIRAL GENETICS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; GENOME, VIRAL; HUMANS; HYPERSENSITIVITY; MICE; PNEUMOVIRUS; PNEUMOVIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES;

EID: 43849098060     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.03.013     Document Type: Review

References (51)

1. Horsfall F.L., and Hahn R.G. A latent virus in normal mice capable of producing pneumonia in its natural host. J Exp Med 71 (1940) 391-408
2. Compans R.W., Harter D.H., and Choppin P.W. Studies on pneumonia virus of mice (PVM) in cell culture. II. Structure and morphogenesis of the virus particle. J Exp Med 126 (1967) 267-276
3. Horsfall F.L., and Ginsberg H.S. The dependence of the pathological lesion upon the multiplication and extent of pneumonia. J Exp Med 93 2 (1951) 139-150
4. Ginsberg H.S., and Horsfall Jr. F.L. Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia. J Exp Med 93 (1951) 161-171
5. Ginsberg H.S., and Horsfall Jr. F.L. Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice as bearing on the inhibition of virus multiplication by bacterial polysaccharides. J Exp Med 89 (1949) 37-52
6. Easton A.J., Domachowske J.B., and Rosenberg H.F. Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev 17 (2004) 390-412
7. Chambers P., Pringle C.R., and Easton A.J. Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins. J Gen Virol 73 (1992) 1717-1724
8. Barr J., and Easton A.J. Characterisation of the interaction between the nucleoprotein and phosphoprotein of pneumonia virus of mice. Virus Res 39 (1995) 221-235
9. Easton A.J., and Chambers P. Nucleotide sequence of the genes encoding the matrix and small hydrophobic proteins of pneumonia virus of mice. Virus Res 48 (1997) 27-33
10. Ahmadian G., Chambers P., and Easton A.J. Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumoviruses. J Gen Virol 80 (1999) 2011-2016
11. Rosenberg H.F., Bonville C.A., Easton A.J., and Domachowske J.B. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther 105 (2005) 1-6
12. Easton AJ, Domachowske JB, Rosenberg HF. Pneumonia virus of mice, in respiratory syncytial virus, Perspectives in Medical Virology, Cane, P editor. vol. 14, Amsterdam, Elsevier Press, 2006, p. 299-319.
13. Anh D.B., Faisca P., and Desmecht D.J. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am J Physiol Lung Cell Mol Physiol 291 (2006) L426-L435
14. Domachowske J.B., Bonville C.A., Easton A.J., and Rosenberg H.F. Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J Infect Dis 186 (2002) 8-14
15. Ellis J.A., Martin B.V., Waldner C., Dyer K.D., Domachowske J.B., and Rosenberg H.F. Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine 25 (2007) 1085-1095
16. Krempl C.D., and Collins P.L. Reevaluation of the virulence of prototypic strain 15 of pneumonia virus of mice. J Virol 78 (2004) 13362-13365
17. Thorpe L.C., and Easton A.J. Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666. J Gen Virol 86 (2005) 159-169
18. Krempl C.D., Lamirande E.W., and Collins P.L. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Genes 30 (2005) 237-249
19. Dibben O., and Easton A.J. Mutational analysis of the gene start sequences of pneumonia virus of mice. Virus Res 130 (2007) 303-309
20. Dibben O., Thorpe L.C., and Easton A.J. Roles of the PVM M2-1. M2-2 and P gene ORF 2 (P-2) proteins in viral replication. Virus Res 131 (2008) 47-53
21. Krempl C.D., Wnekowicz A., Lamirande E.W., Nayebagha G., Collins P.L., and Buchholz U.J. Identification of a novel virulence factor in recombinant pneumonia virus of mice. J Virol 81 (2007) 9490-9501
22. Domachowske J.B., Bonville C.A., Dyer K.D., Easton A.J., and Rosenberg H.F. Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice. Cell Immunol 200 (2000) 98-104
23. Domachowske J.B., Bonville C.A., Gao J.L., Murphy P.M., Easton A.J., and Rosenberg H.F. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol 165 (2000) 2677-2682
24. Bonville C.A., Bennett N.J., Koehnlein M., Haines D.M., Ellis J.A., DelVecchio A.M., et al. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 349 (2006) 87-95
25. Welliver T.P., Garofalo R.P., Hosakote Y., Hintz K.H., Avendano L., Sanchez K., et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195 (2007) 1126-1136
26. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269 (1995) 1583-1585
27. Bonville C.A., Easton A.J., Rosenberg H.F., and Domachowske J.B. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol 77 (2003) 1237-1244
28. Bonville C.A., Lau V.K., DeLeon J.M., Gao J.L., Easton A.J., Rosenberg H.F., et al. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol 78 (2004) 7984-7989
29. Looney R.J., Falsey A.R., Walsh E., and Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis 185 (2002) 682-685
30. Bonville C.A., Bennett N.J., Percopo C.M., Branigan P.J., Del Vecchio A.M., Rosenberg H.F., et al. Diminished inflammatory responses to natural pneumovirus infection among older mice. Virology 368 (2007) 182-190
31. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1 (2000) 398-401
32. Ehl S., Bischoff R., Ostler T., Vallbracht S., Schulte-Mönting J., Poltorak A., et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 34 (2004) 1146-1153
33. Poltorak A., Merlin T., Nielsen P.J., Sandra O., Smirnova I., Schupp I., et al. A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J Immunol 167 (2001) 2106-2111
34. Faisca P., Tran Anh D.B., Thomas A., and Desmecht D. Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection. Microbes Infect 8 (2006) 621-627
35. van der Sluijs K.F., van Elden L., Nijhuis M., Schuurman R., Florquin S., Jansen H.M., et al. Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol Lett 89 (2003) 201-206
36. Groskreutz D.J., Monick M.M., Powers L.S., Yarovinsky T.O., Look D.C., and Hunninghake G.W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 176 (2006) 1733-1740
37. Phipps S., Lam C.E., Mahalingam S., Newhouse M., Ramirez R., Rosenberg H.F., et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110 (2007) 1578-1586
38. Garvey T.L., Dyer K.D., Ellis J.A., Bonville C.A., Foster B., Prussin C., et al. Inflammatory responses to pneumovirus infection in IFNαβR gene-deleted mice. J Immunol 175 (2005) 4735-4744
39. Claassen E.A., van der Kant P.A., Rychnavska Z.S., van Bleek G.M., Easton A.J., and van der Most R.G. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol 175 (2005) 6597-6604
40. + T cell memory in the respiratory tract. Nat Med 8 (2002) 54-60
41. + T cells following paramyxovirus infection of the respiratory tract. J Virol 79 (2005) 3339-3349
42. Claassen E.A., van Bleek G.M., Rychnavska Z.S., de Groot R.J., Hensen E.J., Tijhaar E.J., et al. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity. Virology 368 (2007) 17-25
43. Lukacs N.W., Smit J., Lindell D., and Schaller M. Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma. Contrib Microbiol 14 (2007) 68-82
44. Xepapadaki P., and Papadopoulos N.G. Viral infections and allergies. Immunobiology 212 (2007) 453-459
45. Barends M., de Rond L.G., Dormans J., van Oosten M., Boelen A., Neijens H.J., et al. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice. Clin Exp Allergy 34 (2004) 488-496
46. Prince G.A., Curtis S.J., Yim K.C., and Porter D.D. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J Gen Virol 82 (2001) 2881-2888
47. Ventre K., and Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 1 (2007) CD000181
48. Patel H., Platt R., Lozano J.M., and Wang E.E. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 3 (2004) CD004878
49. Domachowske J.B., Bonville C.A., Ali-Ahmad D., Dyer K.D., Easton A.J., and Rosenberg H.F. Glucocorticoid administration accelerates mortality of pneumovirus-infected mice. J Infect Dis 184 (2001) 1518-1523
50. Thomas L.H., Sharland M., and Friedland J.S. Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants. Pediatr Res 52 (2002) 368-372
51. Bonville C.A., Rosenberg H.F., and Domachowske J.B. Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis. Antiviral Res 69 (2006) 53-59